# A Prospective, Multicenter, Randomized, No-treatment Controlled, Assessor-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Gel for Injection to Improve Temple Hollowing in Chinese Adults

> **NCT06972940** · NA · RECRUITING · sponsor: **AQTIS Medical B.V.** · enrollment: 159 (estimated)

## Conditions studied

- Temple Hollowing

## Interventions

- **DEVICE:** Polycaprolactone (PCL) Based Facial Injectable

## Key facts

- **NCT ID:** NCT06972940
- **Lead sponsor:** AQTIS Medical B.V.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-03
- **Primary completion:** 2024-10-12
- **Final completion:** 2025-12-31
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06972940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06972940, "A Prospective, Multicenter, Randomized, No-treatment Controlled, Assessor-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Gel for Injection to Improve Temple Hollowing in Chinese Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06972940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*